- $1.05bn
- $1.87bn
- $1.37bn
Brief: Conmed Q2 Adjusted EPS USD 1.15 Vs. IBES Estimate USD 1.12
Brief: Conmed enters into eighth ammended credit agreement - SEC filing
U.S. STOCKS ON THE MOVE-Moderna, Cardinal Health, Adobe
U.S. STOCKS ON THE MOVE-CureVac, Conagra, Oklo
Conmed slips after Needham downgrade
U.S. STOCKS ON THE MOVE-Esty, America's Car-Mart, ImmunoPrecise
Conmed slips after Needham downgrade
Brief: Conmed Corporation Appoints Laverne Council As Chair Of The Board Of Directors
U.S. RESEARCH ROUNDUP-Avepoint, Meta, United Therapeutics
Conmed Corp reports results for the quarter ended March 31 - Earnings Summary
U.S. RESEARCH ROUNDUP-Conmed, McKesson, Veralto
Conmed Corp reports results for the quarter ended December 31 - Earnings Summary
Brief: Conmed Q4 Adjusted EPS USD 1.34 Vs. IBES Estimate USD 1.2
Conmed Corp reports results for the quarter ended in September 30 - Earnings Summary
Brief: Conmed Q3 Adjusted EPS USD 1.05 Vs. IBES Estimate USD 0.99
U.S. RESEARCH ROUNDUP-CH Robinson Worldwide, Lam Research, Meta
Conmed Corp reports results for the quarter ended in June - Earnings Summary
Brief: Conmed Q2 Adjusted EPS USD 0.98 Vs. IBES Estimate USD 0.91
Conmed Corp expected to post earnings of 91 cents a share - Earnings Preview